Featured Products


Chattanooga® Continuum™

The Chattanooga® Continuum™ is a portable 2 channel stimulator used by therapists in clinics and patients at home to provide electrical stimulation treatments in pain management (TENS) and neuro muscular stimulation (EMS/NMES).


Chattanooga’s Radial Pressure Wave

The Mobile 2 RPW (Radial Pressure Wave) is compact and light enough to be easily carried while also delivering a host of features and benefits.


MySign S Pulse Oximeter

Setting new standards in pulse oximetry

If stationary or mobile as handheld, if for long-term or spot check measurements, MySign® S allows easy, fast and reliable measuring and monitoring of oxygen saturation in arterial blood and pulse rate.

The trendsetting product design convinced the international jury of renowned experts in the reddot design contest. In future MySign® S may present itself as reddot design award winner 2013.


VascuEase Portable DVT System

VascuEase™represents a new level of care in the pneumatic compression device category for preventing DVT for all non-ambulatory patients during hospital stay or while recovering at home


8 Chamber Sequential Circulator

A gradient sequential compression device designed for the treatment of Lymphedema, Venous Insufficiency, and Wound Healing.


EnteralLite Infinity Enteral Feeding Pump

The EnteraLite® Infinity® is a rotary peristaltic enteral feeding pump designed to deliver programmed doses of enteral nutrition solutions at selectable rates. It is easy to use with a simple user interface and keypad. Moog technology allows an accuracy rate of +/- 5% and the ability to safely operate in any orientation. The EnteraLite Infinity system includes a complete line of DEHP-free pump delivery sets with automatic free-flow protection.


Cefaly Dual

FDA approved device for migraine treatment

Cefaly is a non-drug, non-invasive migraine treatment that offers the best safety/efficacy ratio compared to current anti-migraine medication. It is the first line treatment for patients having frequent migraine attacks. Cefaly enables the use of medicines to be significantly reduced and the sufferer's quality of life to be markedly improved. Cefaly has been approved by the FDA for use under prescription